Ultragenyx (RARE) support and resistance · rev $350.0M
Ultragenyx (RARE) is a biotechnology company listed on US.
This page maps Ultragenyx (RARE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
RARE currently screens at market cap $2.79B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new RARE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the RARE quote page for the session range and the stock page for the full model.
Not investment advice.